ClinicalTrials.govpublic full text
Genetically Modified T-Cells Followed by Aldesleukin in Treating Patients With Stage III-IV Melanoma
metastatic melanoma, stage iii cutaneous melanoma ajcc v7, stage iiia cutaneous melanoma ajcc v7, stage iiib cutaneous melanoma ajcc v7, stage iiic cutaneous melanoma ajcc v7, stage iv cutaneous melanoma ajcc v6 and v7
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 136343
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.